{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:16:59Z","timestamp":1781939819846,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,4]]},"DOI":"10.7759\/cureus.55508","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T22:55:16Z","timestamp":1709592916000},"source":"Crossref","is-referenced-by-count":1,"title":["Fosfomycin-Induced Liver Injury: A Case Report"],"prefix":"10.7759","author":[{"given":"Rui","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judite","family":"Antas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pais Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas ME","year":"2016","unstructured":"Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ. Fosfomycin. Clin Microbiol Rev. 2016, 29:321-47. 10.1128\/CMR.00068-15","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-015-0092-8","article-title":"Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA Adverse Event Reporting System database","volume":"4","author":"Iarikov D","year":"2015","unstructured":"Iarikov D, Wassel R, Farley J, Nambiar S. Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA Adverse Event Reporting System database. Infect Dis Ther. 2015, 4:433-58. 10.1007\/s40121-015-0092-8","journal-title":"Infect Dis Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019, 70:1222-61. 10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"key":"ref4","article-title":"Fosfomycin","year":"2012","unstructured":"Fosfomycin. LiverTox. clinical and research information on drug-induced liver injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.131","article-title":"ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani NP","year":"2014","unstructured":"Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014, 109:950-66. 10.1038\/ajg.2014.131","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan G","year":"2015","unstructured":"Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015, 17:14. 10.3390\/ijms17010014","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2013.09.005","article-title":"Evaluation of abnormal liver tests","volume":"98","author":"Woreta TA","year":"2014","unstructured":"Woreta TA, Alqahtani SA. Evaluation of abnormal liver tests. Med Clin North Am. 2014, 98:1-16. 10.1016\/j.mcna.2013.09.005","journal-title":"Med Clin North Am"},{"key":"ref8","article-title":"Flavoxate","year":"2012","unstructured":"Flavoxate. LiverTox. clinical and research information on drug-induced liver injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.11405\/nisshoshi.102.1207","article-title":"[A case of acute severe hepatitis induced by fosfomycin] (Article in Japanese)","volume":"102","author":"Matsumori A","year":"2005","unstructured":"Matsumori A, Yoneda S, Kobayashi Y, et al.. [A case of acute severe hepatitis induced by fosfomycin] (Article in Japanese). Nihon Shokakibyo Gakkai Zasshi. 2005, 102:1207-11. 10.11405\/nisshoshi.102.1207","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/003655401750174200","article-title":"Acute, recurrent fosfomycin-induced liver toxicity in an adult patient with cystic fibrosis","volume":"33","author":"Durupt S","year":"2001","unstructured":"Durupt S, Josserand RN, Sibille M, Durieu I. Acute, recurrent fosfomycin-induced liver toxicity in an adult patient with cystic fibrosis. Scand J Infect Dis. 2001, 33:391-2. 10.1080\/003655401750174200","journal-title":"Scand J Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2009.00385.x","article-title":"Drug-induced liver disease: an 8-year study of patients from one gastroenterological department","volume":"10","author":"Wang YP","year":"2009","unstructured":"Wang YP, Shi B, Chen YX, Xu J, Jiang CF, Xie WF. Drug-induced liver disease: an 8-year study of patients from one gastroenterological department. J Dig Dis. 2009, 10:195-200. 10.1111\/j.1751-2980.2009.00385.x","journal-title":"J Dig Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpg.2012.04.003","article-title":"Acute hepatitis induced by fosfomycin: a case report and review of the literature","volume":"19","author":"Ferreira R","year":"2012","unstructured":"Ferreira R, Torres J, Raposo J, Ferreira M, Mendes S, Agostinho C, Campos MJ. Acute hepatitis induced by fosfomycin: a case report and review of the literature. GE Port J Gastroenterol. 2012, 19:263-6. 10.1016\/j.jpg.2012.04.003","journal-title":"GE Port J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226822-fosfomycin-induced-liver-injury-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T22:55:25Z","timestamp":1709592925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226822-fosfomycin-induced-liver-injury-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.55508","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,4]]}}}